Executive Director, Global Medical Oncology, Iza-Bren Medical Product Lead (MPL)
Core
Lead the global medical team for Izabren, a first-in-class EGFRxHER3 bispecific antibody-drug conjugate (ADC), driving clinical evidence generation, recruitment, and external advocacy across international markets for breast, lung, gastrointestinal, and genitourinary cancers.
Role type
Executive Director, Global Medical Product Lead (MPL)
Builds
Clinical evidence and medical strategy for a multi-tumor ADC program
Domain
Oncology, ADCs, bispecific antibodies, solid tumors
Required skills
Global medical strategy, team leadership, trial execution, competitive landscape analysis, budget management, KPI monitoring, cross-functional partnership, scientific advocacy, stakeholder management, project management, change management
Preferred skills
ADC/bispecific antibody experience, Phase 3 oncology development, solid tumor expertise (breast, thoracic, GI, GU), alliance partner collaboration
Technologies
ADCs, bispecific antibodies, Phase 3 studies
Responsibilities
Develop and execute unified global medical strategy; lead and manage global and US medical teams; optimize trial execution and site engagement; monitor competitive landscape; oversee resource allocation and budget management; establish KPIs and reporting tools; partner with Clinical Development, Safety, and Regulatory teams; support building regional leads and MSL teams; shape external perception and engage key opinion leaders
Seniority
Executive, strategic leadership